BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Poggio PD, Zaccanelli M, Oggionni M, Colombo S, Jamoletti C, Puhalo V. Low-dose tenofovir is more potent than adefovir and is effective in controlling HBV viremia in chronic HBeAg-negative hepatitis B. World J Gastroenterol 2007; 13(30): 4096-4099 [PMID: 17696228 DOI: 10.3748/wjg.v13.i30.4096]
URL: https://www.wjgnet.com/1007-9327/full/v13/i30/4096.htm
Number Citing Articles
1
Julie Fox, Simon Collins. HIV preventionAIDS 2017; 31(9): 1343 doi: 10.1097/QAD.0000000000001456
2
Chantelli Iamblaudiot Razafindrazoto, Tovo Harimanana Rabenjanahary, Andry Lalaina Rinà Rakotozafindrabe, Sedera Radoniaina Rakotondrasoa, Nitah Harivony Randriamifidy, Anjaramalala Sitraka Rasolonjatovo, Soloniaina Hélio Razafimahefa, Rado Manitrala Ramanampamonjy, Haruki Komatsu. Effectiveness and Safety of Low Dose of Tenofovir Disoproxil Fumarate in Malagasy Patients with Chronic Hepatitis BBioMed Research International 2022; 2022: 1 doi: 10.1155/2022/1654620
3
R. Morillo Verdugo, A. Madrazo Berenguer, M.V. Gil Navarro, E. Suárez García. Tratamiento farmacológico de la hepatitis BFarmacia Hospitalaria 2008; 32(4): 234 doi: 10.1016/S1130-6343(08)75937-3
4
Mamta K. Jain, Cindy L. Zoellner, Kanan Garg. Pharmacotherapy of Chronic Hepatitis B in Adults: Focus on Tenofovir Disoproxil FumarateClinical Medicine. Therapeutics 2009; 1 doi: 10.4137/CMT.S1161
5
Susanne Beckebaum, Georgios C. Sotiropoulos, Guido Gerken, Vito R. Cicinnati. Hepatitis B and liver transplantation: 2008 updateReviews in Medical Virology 2009; 19(1): 7 doi: 10.1002/rmv.595
6
Daryl T.-Y. Lau, Wissam Bleibel. Review: Current status of antiviral therapy for hepatitis BTherapeutic Advances in Gastroenterology 2008; 1(1): 61 doi: 10.1177/1756283X08093944
7
Kin Seng Liem, David K. Wong, Scott Fung, Alireza Zahirieh, Colina Yim, Wayel R. Zanjir, Jordan J. Feld, Bettina E. Hansen, Harry L. A. Janssen. Maintained virological suppression and renal function with reduced dose tenofovir disoproxil fumarate in renally impaired chronic hepatitis B patientsJournal of Viral Hepatitis 2021; 28(1): 51 doi: 10.1111/jvh.13401
8
E. Paintsil, Y.-C. Cheng. Reference Module in Biomedical Sciences2014;  doi: 10.1016/B978-0-12-801238-3.02387-4
9
R. Morillo Verdugo, A. Madrazo Berenguer, M.V. Gil Navarro, E. Suárez García. Drugs Treatment of Hepatitis BFarmacia Hospitalaria (English Edition) 2008; 32(4): 234 doi: 10.1016/S2173-5085(08)70045-5
10
Erik De Clercq. Another ten stories in antiviral drug discovery (part C): “Old” and “new” antivirals, strategies, and perspectivesMedicinal Research Reviews 2009; 29(4): 611 doi: 10.1002/med.20153
11
Erik De Clercq, Geoffrey Férir, Suzanne Kaptein, Johan Neyts. Antiviral Treatment of Chronic Hepatitis B Virus (HBV) InfectionsViruses 2010; 2(6): 1279 doi: 10.3390/v2061279
12
Dan-Hong Yang, Yuan-Jun Xie, Nian-Feng Zhao, Hong-Ying Pan, Ming-Wei Li, Hai-Jun Huang. Tenofovir disoproxil fumarate is superior to lamivudine plus adefovir in lamivudine-resistant chronic hepatitis B patientsWorld Journal of Gastroenterology 2015; 21(9): 2746-2753 doi: 10.3748/wjg.v21.i9.2746
13
Hie-Won Hann, Hee Bok Chae, Stephen R. Dunn. Tenofovir (TDF) has stronger antiviral effect than adefovir (ADV) against lamivudine (LAM)-resistant hepatitis B virus (HBV)Hepatology International 2008; 2(2): 244 doi: 10.1007/s12072-008-9045-6
14
Dennis J. Cada, Terri L. Levien, Danial E. Baker. Tenofovir Disoproxil Fumarate TabletsHospital Pharmacy 2009; 44(2): 165 doi: 10.1310/hpj4402-165
15
Seng Gee Lim, Guan Huei Lee, Kieron Lim, Poh Seng Tan. Resistance is no Longer a Problem with Entecavir and TenofovirCurrent Hepatitis Reports 2013; 12(2): 96 doi: 10.1007/s11901-013-0168-4
16
Alice M. Jenh, Chloe L. Thio, Paul A. Pham. Tenofovir for the Treatment of Hepatitis B VirusPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 2009; 29(10): 1212 doi: 10.1592/phco.29.10.1212
17
Lauren M Hynicka, Nancy Yunker, Punam H Patel. A Review of Oral Antiretroviral Therapy for the Treatment of Chronic Hepatitis BAnnals of Pharmacotherapy 2010; 44(7-8): 1271 doi: 10.1345/aph.1M590
18
Alice M Jenh, Paul A Pham. Tenofovir disoproxil fumarate in the treatment of chronic hepatitis BExpert Review of Anti-infective Therapy 2010; 8(10): 1079 doi: 10.1586/eri.10.91
19
Michael T. Yin, James C. M. Brust, Hong Van Tieu, Scott M. Hammer. Clinical Virology2009; : 217 doi: 10.1128/9781555815981.ch12